Restricted accessResearch articleFirst published online 2020-8
Thrombogenicity of the p48 and anti-thrombogenic p48 hydrophilic polymer coating low-profile flow diverters in an in vitro human thrombin generation model
The implantation of flow diverters, or stents in general, necessitates the use of dual anti-platelet treatment with typical regimes including aspirin and a P2Y12 inhibitor. This carries an inherent risk of haemorrhage. We sought to compare the thrombogenicity of the anti-thrombogenic p48 hydrophilic polymer coating compared to the standard uncoated p48 flow diverter using an in vitro thrombogenicity assay.
Methods
To evaluate the thrombin generation influenced by the different stent types the stents were placed in wells of a 24-well plate with the addition of plasma from healthy volunteers the thrombin calibrator respectively the PPP-reagent was added. Subsequently, the thrombin substrate was added and the thrombin generation was analysed every 60 s using a thrombinoscope. The assay is calibrated using samples containing a known amount of active thrombin in PPP. Thrombin activity is proportional to the change in fluorescence.
Results
The p48 hydrophilic polymer coating shows a significantly lower peak thrombin concentration (1.13 ± 0.21 vs. 1.41 ± 0.22) and longer time to peak thrombin concentration (0.96 ± 0.04 vs. 0.74 ± 0.07) compared to the uncoated p48 device (p < 0.01). The responses of the p48 hydrophilic polymer coating were similar to that of the negative control.
Conclusion
The hydrophilic polymer coating surface modification significantly reduces the thrombogenicity of the p48 flow diverter. These results corroborate the findings from previous in vitro studies.
BecskeTKallmesDFSaatciI, et al.
Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial.Radiology2013;
267: 858–868.
2.
BecskeTBrinjikjiWPottsMB, et al.
Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms: five-year results of the pipeline for uncoilable or failed aneurysms trial.Neurosurgery2017;
80: 40–48.
3.
SirakovSSirakovABhogalP, et al.
The p64 flow diverter-mid-term and long-term results from a single center.Clin Neuroradiol2019.
4.
KadirvelRDingY-HDaiD, et al.
Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter.Radiology2014;
270: 394–399.
5.
GuptaRMooreJMGriessenauerCJ, et al.
Assessment of dual-antiplatelet regimen for pipeline embolization device placement: a survey of major academic neurovascular centers in the United States.World Neurosurg2016;
96: 285–292.
6.
CheungNKCarrMWRayU, et al.
Platelet function testing in neurovascular procedures: tool or gimmick?Interv Neurol2019;
8: 123–134.
7.
AjadiEKabirSCookA, et al.
Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis.J NeuroInterventional Surg2019; neurintsurg-2019-014765.
8.
RaychevRTateshimaSVinuelaF, et al.
Predictors of thrombotic complications and mass effect exacerbation after pipeline embolization: the significance of adenosine diphosphate inhibition, fluoroscopy time, and aneurysm size. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci2016;
22: 34–41.
9.
BergerPBBhattDLFusterV, et al.
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial. Circulation2010;
121: 2575–2583.
10.
BodilyKDCloftHJLanzinoG, et al.
Stent-assisted coiling in acutely ruptured intracranial aneurysms: a qualitative, systematic review of the literature.AJNR Am J Neuroradiol2011;
32: 1232–1236.
11.
BhogalPHenkesESchobS, et al.
The use of flow diverters to treat small (≤5 mm) ruptured, saccular aneurysms.Surg Neurol Int2018;
9: 216.
12.
BhogalPBrouwerPASöderqvistÅK, et al.
Patients with subarachnoid haemorrhage from vertebrobasilar dissection: treatment with stent-in-stent technique.Neuroradiology2015;
57: 605–614.
13.
MokinMChineaAPrimianiCT, et al.
Treatment of blood blister aneurysms of the internal carotid artery with flow diversion.J NeuroInterventional Surg2018; 10(11): 1074–1078.
14.
HellsternVAguilar-PérezMAlMatterM, et al.
Microsurgical clipping and endovascular flow diversion of ruptured anterior circulation blood blister-like aneurysms.Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci2018;
24: 615–623.
15.
AlMatterMAguilar PérezMHellsternV, et al.
Flow diversion for treatment of acutely ruptured intracranial aneurysms : a single center experience from 45 consecutive cases.Clin Neuroradiol2019.
16.
CagnazzoFdi CarloDTCappucciM, et al.
Acutely ruptured intracranial aneurysms treated with flow-diverter stents: a systematic review and meta-analysis.AJNR Am J Neuroradiol2018;
39: 1669–1675.
17.
Lenz-HabijanTBhogalPPetersM, et al.
Hydrophilic stent coating inhibits platelet adhesion on stent surfaces: initial results in vitro. Cardiovasc Intervent Radiol2018; 41(11): 1779–1785.
18.
Lenz-HabijanTBroddeMKehrelBE, et al.
Comparison of the thrombogenicity of a bare and antithrombogenic coated flow diverter in an in vitro flow model. Cardiovasc Intervent Radiol2019.
19.
BhogalPLenz-HabijanTBannewitzC, et al.
The pCONUS HPC: 30-day and 180-day in vivo biocompatibility results. Cardiovasc Intervent Radiol2019.
20.
HemkerHC.The application of thrombin generation in real life clinical situations.Thromb Res2015;
136: 3–4.
21.
HemkerHCBéguinS.Thrombin generation in plasma: its assessment via the endogenous thrombin potential.Thromb Haemost1995;
74: 134–138.
22.
HemkerHCGiesenPAlDieriR, et al.
The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability.Pathophysiol Haemost Thromb2002;
32: 249–253.
23.
HemkerHCGiesenPAl DieriR, et al.
Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb2003;
33: 4–15.
GirdharGReadMSohnJ, et al.
In-vitro thrombogenicity assessment of polymer filament modified and native platinum embolic coils.J Neurol Sci2014;
339: 97–101.
26.
YoungGSørensenBDargaudY, et al.
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives.Blood2013;
121: 1944–1950.
27.
HronGKollarsMBinderBR, et al.
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA2006;
296: 397–402.
28.
BesserMBaglinCLuddingtonR, et al.
High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.J Thromb Haemost JTH2008;
60: 1720–1725.
29.
GirdharGLiJKostousovLWainwrightJ, et al.
In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices. J Thromb Thrombolysis2015;
40: 437–443.
30.
FaucheuxNSchweissRLützowK, et al.
Self-assembled monolayers with different terminating groups as model substrates for cell adhesion studies.Biomaterials2004;
25: 2721–2730.
31.
WanGJHuangNYangP, et al.
Platelet activation behavior on nitrogen plasma-implanted silicon. Mater Sci Eng C2007;
27: 928–932.
32.
YangPHuangNLengYX, et al.
Wettability and biocompatibility of nitrogen-doped hydrogenated amorphous carbon films: effect of nitrogen. Nucl Instrum Methods Phys Res Sect B Beam Interact Mater At2006;
242: 22–25.
33.
TzonevaRGrothTAltankovG, et al.
Remodeling of fibrinogen by endothelial cells in dependence on fibronectin matrix assembly. Effect of substratum wettability. J Mater Sci Mater Med2002;
13: 1235–1244.
34.
ArimaYIwataH.Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers.Biomaterials2007;
28: 3074–3082.
35.
ColganFAguilar PérezMHellsternV, et al. Vertebral artery aneurysm: ruptured dissecting aneurysm, implantation of telescoping p48_HPC flow diverter stents under antiaggregation with ASA only. In: HHenkesPLylykOGanslandt (eds) The Aneurysm Casebook: A Guide to Treatment Selection and Technique [Internet].
Cham:
Springer International Publishing, 2018, pp. 1–16. Available at: 10.1007/978-3-319-70267-4_80-1 (accessed 19 April 2019).
36.
BhogalPBleiseCChudykJ, et al.
The p48_HPC antithrombogenic flow diverter: initial human experience using single antiplatelet therapy. J Int Med Res2019;
48: 300060519879580.
37.
PerezMAAlMatterMHellsternV, et al.
Use of the pCONus HPC as an adjunct to coil occlusion of acutely ruptured aneurysms: early clinical experience using single antiplatelet therapy.J NeuroInterventional Surg2020. Available at: http://jnis.bmj.com/content/early/2020/02/26/neurintsurg-2019-015746 (accessed 31 March 2020).
